# US 2025/0144384 A1 · Ingestible device with detachment of tissue penetrating member

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144384 A1
- Document ID: US20250144384A1
- Status: Published application
- Kind: A1
- Application number: 18/832,669
- Filed: 2024-01-31
- Published: 2025-05-08
- Earliest claimed: 2022-01-31
- Applicants: Novo Nordisk A/S
- Inventors: Aghiad Ghazal; Brian Jensen; Maria Pereverzina; Drago Sticker; Jacob Pyung Hwa Jepsen; Brian Mouridsen; Cody Edward Cleveland; Mette Poulsen; Anders Hagedal Uhrenfeldt; Anders Hammelev Marstrand; Noekkvi Steinn Sigurdarson; Adam Bo Mandel; Camilla Sandfeld; Jesper Peter Windum; Nicolai Aaberg Hansen; Kristina Ray Rivera
- Web page: https://patentgrep.com/patent/US20250144384A1

## CPC

- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61M 2202/0007: introduced into the body
- A61M 2202/04: Liquids
- A61M 2202/064: Powder
- A61M 2205/02: characterised by a particular materials
- A61M 2210/1042: Alimentary tract (A61M2210/0618 takes precedence)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An ingestible device (200), comprising: a housing (210, 220) comprising a stop geometry (228) at an exit hole (224); a tissue penetrating member (230) and an actuator that comprises: a pushing portion (260) configured for axial movement from a first to a second position, the pushing portion configured to move the tissue penetrating member from within the housing to a lodged position in tissue, and a holder portion (270) coupled with the pushing portion (260) for initial axial movement with the pushing portion. In the first position the holder portion releasably holds the tissue penetrating member (230) in axial retaining engagement. As the pushing portion (260) moves towards the second position, the tissue penetrating member (230) moves through the exit hole (224) until the holder portion (270) enters into engagement with the stop geometry (228). The pushing portion (260) moves further to release and advance the tissue penetrating member (230).

## Claims

### Claim 1

An ingestible device suitable for swallowing into a lumen of a gastrointestinal tract of a patient, the lumen having a lumen wall, the ingestible device comprising:
a housing defining an internal hollow and comprising a stop geometry arranged within the internal hollow and an exit hole,
a tissue penetrating member disposable in the housing, the tissue penetrating member having a tissue penetrating first end, a second end opposite the first end and a radially outwards facing surface between the first end and the second end, and
an actuator arrangement comprising:
a) a pushing portion configured for movement along an axis from a first position and into a second position, the pushing portion being configured for providing a force onto the tissue penetrating member to move the tissue penetrating member from an initial position within the housing to a lodged position where at least a portion of the tissue penetration member is external to the housing and at least partially lodged in tissue of the lumen wall, and
b) a holder portion coupled with the pushing portion for initial axial movement with the pushing portion, wherein when the pushing portion assumes the first position the holder portion releasably holds the tissue penetrating member in axial retaining engagement,
wherein, as the pushing portion moves towards the second position, the tissue penetrating member is moved into tissue until the holder portion enters into engagement with the stop geometry of the housing thereby axially stopping the holder portion, whereafter the pushing portion moves further to release the axial retaining engagement and advance the tissue penetrating member into its lodged position.

### Claim 2 (depends on 1)

The ingestible device as in claim 1, wherein, when the tissue penetrating member assumes the initial position, the holder portion assumes a start position, and wherein the holder portion is moved from the start position towards the stop geometry by slaved movement relative to the pushing portion.

### Claim 3 (depends on 2)

The ingestible device as in claim 2, wherein the holder portion, when assuming the start position, releasably engages the pushing portion, such as by a friction engagement or a snap engagement, and wherein the pushing portion releases from engagement with the holder portion when the holder portion enters into engagement with the stop geometry.

### Claim 4 (depends on 2)

The ingestible device as in claim 2, wherein the holder portion is formed as a sleeve that, when the holder portion is slaved relative to the pushing portion, interconnects the pushing portion with the tissue penetrating member.

### Claim 5 (depends on 1)

The ingestible device as in claim 1, wherein the holder portion comprises at least one radially resilient gripping member providing a radially inwards directed force onto the tissue penetrating member, wherein the radially resilient gripping member cooperates with the stop geometry of the housing to release the radially inwards directed force upon the holder portion engaging the stop geometry.

### Claim 6 (depends on 1)

The ingestible device as in claim 1, wherein the holder portion defines a distal facing end surface and wherein, when the holder portion holds the tissue penetrating member in axial retaining engagement, the distal facing end surface at least partially encircles the tissue penetration member while the tissue penetrating member extends distally from the distal facing end surface of the holder portion.

### Claim 7 (depends on 1)

The ingestible device as in claim 1, wherein the holder portion comprises at least one piercing portion that protrudes axially from the distal facing end surface, the at least one piercing portion extending axially past the first end of the tissue penetrating member.

### Claim 8 (depends on 1)

The ingestible device as in claim 1, wherein the housing comprises an exterior surface portion surrounding the exit hole, wherein the exit hole permits the tissue penetrating member, the holder portion and the pushing portion to protrude through the exit hole, and wherein the pushing portion in its second position pushes the first end of the tissue penetrating member a predefined distance from the exterior surface portion, said pre-defined distance selected between 3 and 7 mm.

### Claim 9 (depends on 1)

The ingestible device as in claim 1, wherein, when the tissue penetrating member assumes the initial position, the tissue penetrating first end is axially separated relative to an exterior surface portion surrounding the exit hole by a separating distance, thereby enabling the tissue penetrating member to be advanced towards tissue at a target location by an acceleration stroke corresponding to the separating distance.

### Claim 10 (depends on 1)

The ingestible device as in claim 1, wherein the pushing portion and the holder portion comprises a protruding section configured to protrude through the exit hole, and wherein at least a portion of the said protruding sections are made from a material configured to change shape, such as by degrading, softening or swelling, when exposed to a biologic fluid, such as gastric fluid.

### Claim 11 (depends on 1)

The ingestible device as in claim 1, wherein the tissue penetrating member is a solid formed partly or entirely from a preparation comprising a therapeutic payload, wherein the tissue penetrating member is made from a dissolvable material that dissolves when inserted into tissue of the lumen wall to deliver at least a portion of the therapeutic payload into tissue.

### Claim 12 (depends on 1)

The ingestible device as in claim 1, wherein an exterior portion of the tissue penetrating member defines an enclosure, and wherein a preparation comprising a therapeutic active substance forms a liquid, gel or powder accommodated within the enclosure.

### Claim 13 (depends on 1)

The ingestible device as in claim 1, wherein the actuator arrangement comprises an energy source configured for powering the tissue penetrating member for being advanced from the housing and into the lodged position in the lumen wall and wherein a trigger arrangement is coupled to the actuator arrangement for initiating release of energy from the energy source thereby driving the pushing portion from the first position to the second position.

### Claim 14 (depends on 13)

The ingestible device as in claim 13, wherein the energy source comprises a drive spring, such as a compression spring or a tension spring, the spring being strained or configured for being strained so as to provide an axial load on the pushing portion for driving movement of the pushing portion from the first position to the second position.

### Claim 15 (depends on 1)

The ingestible device as in claim 1, wherein the ingestible device is configured as a self-orienting capsule device, wherein when the self-orienting capsule device is at least partially supported by the tissue of the lumen wall, the self-orienting capsule device orients in a direction to allow the tissue penetrating member to be inserted into the lumen wall.

### Claim 16 (depends on 8)

The ingestible device as in claim 8, wherein the pre-defined distance selected is between 4 and 6 mm.

### Claim 17 (depends on 8)

The ingestible device as in claim 8, wherein the pre-defined distance selected is between 4.5 and 5.5 mm.
